BioCentury
ARTICLE | Financial News

Follow-on roundup: Sangamo, Tricida, DBV

April 4, 2019 7:34 PM UTC

Sangamo and Tricida each priced follow-ons soon after their share prices spiked on recent clinical readouts. DBV also raised a follow-on ahead of a planned BLA resubmission.

Sangamo Therapeutics Inc. (NASDAQ:SGMO) raised $126.5 million on Thursday through the sale of 11 million shares at $11.50. The price is a 12% discount to its closing price of $13.03 on Wednesday, when it proposed the offering after market hours. Underwriters are Cowen, Wells Fargo and Barclays...